Wells Fargo
PROK icon

Wells Fargo’s ProKidney PROK Stock Holding History

Wells Fargo’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,000
Closed -$6.72K – 7393
2025
Q4 		$6.72K Hold
3,000
– – ﹤0.01% 6023
2025
Q3 		$7.26K Buy
3,000
+2,117
+240% +$5.63K ﹤0.01% 6006
2025
Q2 		$523 Sell
883
-55,234
-98% -$43K ﹤0.01% 6368
2025
Q1 		$49.2K Buy
56,117
+2,019
+4% +$2.8K ﹤0.01% 5404
2024
Q4 		$91.4K Buy
54,098
+18,431
+52% +$33.2K ﹤0.01% 5247
2024
Q3 		$68.5K Buy
35,667
+13,642
+62% +$31K ﹤0.01% 5216
2024
Q2 		$54.2K Buy
22,025
+6,688
+44% +$18K ﹤0.01% 5263
2024
Q1 		$25.2K Buy
15,337
+2,156
+16% +$3.17K ﹤0.01% 5507
2023
Q4 		$23.5K Buy
13,181
+2,709
+26% +$5.81K ﹤0.01% 5585
2023
Q3 		$48K Sell
10,472
-13,240
-56% -$127K ﹤0.01% 5195
2023
Q2 		$265K Buy
23,712
+23,640
+32,833% +$252K ﹤0.01% 4401
2023
Q1 		$815 Sell
72
-7
-9% -$75 ﹤0.01% 6436
2022
Q4 		$542 Buy
79
+10
+14% +$96 ﹤0.01% 6367
2022
Q3 		$1K Buy
+69
New +$600 ﹤0.01% 6431

Other funds holding PROK

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
AGP
Artia Global Partners Miami, Florida $499M AUM 186.05% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wells Fargo's PROK Position: Q1 2026 in Review

Wells Fargo sold out of ProKidney (PROK) in Q1 2026, closing a stake of 3,000 shares — an estimated $6.72K sold.

Wells Fargo first reported a position in PROK in Q3 2022 and held it in 14 quarters. The position peaked at $265K in Q2 2023. 71 funds tracked by Wall St. Rank hold PROK as of Q1 2026.

  • Wells Fargo reported no remaining ProKidney position as of Q1 2026 after selling out during the quarter.
  • Wells Fargo sold 3,000 ProKidney shares in Q1 2026, an estimated $6.72K.
  • Wells Fargo first reported a position in ProKidney in Q3 2022 and held it in 14 quarters.
  • Wells Fargo's ProKidney position peaked at $265K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held ProKidney as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.